Achieve Life Sciences Inc (SP4P) — Cash Flow-to-Debt Ratio
Achieve Life Sciences Inc (SP4P) has a Cash Flow-to-Debt Ratio of -0.89x as of December 2025, meaning its operating cash flow of €-17.98 Million could theoretically repay -1% of its total liabilities (€20.27 Million) in one year. See Achieve Life Sciences Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Achieve Life Sciences Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Achieve Life Sciences Inc across 10 annual periods. Also explore Achieve Life Sciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Achieve Life Sciences Inc (2016–2025)
Year-by-year debt coverage analysis for Achieve Life Sciences Inc. For market capitalisation and broader financial context, see Achieve Life Sciences Inc (SP4P) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | €-49.47 Million | €20.27 Million | ▼ -45.4% |
| 2024 | -1.68x | €-29.77 Million | €17.73 Million | ▼ -42.8% |
| 2023 | -1.18x | €-24.48 Million | €20.82 Million | ▲ +32.1% |
| 2022 | -1.73x | €-37.55 Million | €21.67 Million | ▼ -14.6% |
| 2021 | -1.51x | €-29.44 Million | €19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | €-13.47 Million | €3.01 Million | ▲ +11.0% |
| 2019 | -5.03x | €-15.22 Million | €3.03 Million | ▼ -55.3% |
| 2018 | -3.24x | €-10.62 Million | €3.28 Million | ▲ +28.5% |
| 2017 | -4.52x | €-9.11 Million | €2.01 Million | ▼ -18946.0% |
| 2016 | -0.02x | €-202.00K | €8.50 Million | — |